WLKP | Ticker Profile - Titan Protect

WLKP

Westlake Chemical Partners LP

Basic Materials · Chemicals · NYQ

$23.14

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$802M

Total market value of the company

Trailing P/E

13.87

Reasonably valued

Forward P/E

12.25

Based on estimated future earnings — lower means cheaper

Rev Growth

+28.6%

Year-over-year revenue change

Profit Margin

4.7%

How much profit the company keeps from each dollar of revenue

ROE

42.4%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$25.50

+10% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 2 analysts covering this stock

About Westlake Chemical Partners LP

Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. It's ethylene production facilities which primarily convert ethane into ethylene. The company also sells ethylene co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis. It serves as the general partner of the company. Westlake Chemical Partners LP was founded in 1991 and is headquartered in Houston, Texas.

https://www.wlkpartners.com

Country: United States Industry: Chemicals

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

0.642

Good returns relative to risk taken

Kelly Fraction

0.0362

Modest edge detected — smaller position warranted

Calmar Ratio

0.446

Drawdown risk outweighs the returns — higher risk profile

Annual Return

9.7%

Historical annualised return based on price data

Max Drawdown

-21.8%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.51

Less volatile than the market — more defensive

52W High

$23.88

3% below the year high

52W Low

$17.75

30% above the year low

Avg Volume

30,306

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.9

Days it would take all short sellers to cover — higher means more crowded

Short % Float

0.5%

Low short interest — limited bearish positioning

Div Yield

829.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$1.64

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

50.44

Heavy leverage — higher financial risk if revenues decline

Current Ratio

3.65

Strong balance sheet — comfortably covers short-term obligations

Quick Ratio

3.57

Like current ratio but excludes inventory — stricter test

Gross Margin

31.4%

Revenue left after cost of goods — higher means pricing power

Operating Margin

28.3%

Profit from core operations before interest and tax

Free Cash Flow

$225M

Positive — the business generates more cash than it spends

Revenue (TTM)

$1.2B

Total revenue over the last 12 months

Net Income

$58M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$28.00

Target Median

$25.50

Target Low

$23.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go